Patent ID: 7875646
Filing Date: 2011-01-25
Classification: A61P,C07D

Abstract:
1. A method for the treatment of a disease selected from the group consisting of depression, substance dependence and withdrawal disorder, cognitive disorder, disorders of attention and vigilance, metabolic disorder, disorders of craving, disorders of appetite, obesity, type II diabetes, metabolic syndrome, dyslipidemia, pain, neuropathic pain, pain induced by anticancer treatment, gastrointestinal disorder, vomiting, diarrhea, ulcer, liver disease, rheumatoid arthritis, demyelinization, multiple sclerosis, Alzheimer's, Parkinson's, schizophrenia and tobacco withdrawal comprising administering to a patient in need of said treatment a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof: in which: R 1 represents a (C R R R R R n represents 0, 1 or 2; and Alk represents a (C